Compare IDXX & CBRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IDXX | CBRE |
|---|---|---|
| Founded | 1983 | 1906 |
| Country | United States | United States |
| Employees | N/A | 44000 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1B | 50.7B |
| IPO Year | 1996 | 2001 |
| Metric | IDXX | CBRE |
|---|---|---|
| Price | $602.19 | $134.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $715.00 | $180.43 |
| AVG Volume (30 Days) | 437.8K | ★ 3.2M |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 22.59 | ★ 22.61 |
| EPS | ★ 13.08 | 3.85 |
| Revenue | $4,303,702,000.00 | ★ $40,550,000,000.00 |
| Revenue This Year | $10.83 | $14.53 |
| Revenue Next Year | $8.60 | $9.05 |
| P/E Ratio | $46.46 | ★ $35.54 |
| Revenue Growth | 10.42 | ★ 13.37 |
| 52 Week Low | $356.25 | $108.45 |
| 52 Week High | $769.98 | $174.27 |
| Indicator | IDXX | CBRE |
|---|---|---|
| Relative Strength Index (RSI) | 35.37 | 31.01 |
| Support Level | $516.46 | $125.78 |
| Resistance Level | $657.26 | $136.89 |
| Average True Range (ATR) | 17.97 | 4.22 |
| MACD | -2.34 | -0.72 |
| Stochastic Oscillator | 11.20 | 17.30 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.